VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder
Condition:   Overactive Bladder Interventions:   Drug: Mirabegron 25mg;   Drug: Solifenacin Succinate 5 MG Sponsor:   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2018 Category: Research Source Type: clinical trials